Amyotrophic Lateral Sclerosis Market Size was USD 490 Million in 2021

According to DelveInsight, Amyotrophic Lateral Sclerosis Market was USD 490 million in 2021, and it is estimated to grow during the study period of 2019-2032. Modern therapeutic strategies comprise of neuroprotective treatment focused on antiglutamatergic, antioxidant, antiapoptotic, and anti-inflammatory molecules. Drugs approved for the treatment of Amyotrophic Lateral Sclerosis are IV Radicava (Mitsubishi Tanabe Pharma), Rilutek/Riluzole) (Sanofi/Covis), Exservan (Aquestive Therapeutics), and Tiglutik/ Teglutik (ITF Pharma).